LNA
Live / Registered — Registered and renewed (as of 11 Apr 2024)
What this means for you
Registered since 30 Dec 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Dec 2023).
Record
- Serial number
- 76298889
- Registration number
- 2799671
- Mark type
- Word mark
- Filed
- 14 Aug 2001
- Published for opposition
- 07 Oct 2003
- Registered
- 30 Dec 2003
- Next maintenance due
- 30 Dec 2023
- Attorney of record
- Victoria Friedman
Goods and services
- Class 001 — Chemicals: Synthetic biomolecules, namely, synthetic nucleoside, nucleotide, and nucleic acid for scientific or medical research use
- Class 005 — Pharmaceuticals: Synthetic biomolecules, namely, synthetic nucleoside, nucleotide, and nucleic acid for clinical or medical laboratory use
Owner
- QIAGEN GMBH, HILDEN, DE
- Exiqon A/S, Vedbaek, DK
- Exiqon A/S, Vedbaek, DK
- Exiqon A/S, Vedbaek, DK
Prosecution history
- 11 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Apr 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 11 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Nov 2023 — TEAS SECTION 8 & 9 RECEIVED
- 30 Dec 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Feb 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 Oct 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 31 Oct 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 31 Oct 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Oct 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 31 Oct 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Oct 2013 — TEAS SECTION 8 & 9 RECEIVED
- 09 Dec 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Dec 2009 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL